http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004323372-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
filingDate 2003-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4957ce389d969ed9442f04847d9f309
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e914184b4034b9d25a5c6a59c7b2c152
publicationDate 2004-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2004323372-A
titleOfInvention Benzoazepine compound and method for producing the same
abstract An object of the present invention is to provide an industrially advantageous production method which is most suitable for mass synthesis of a benzazepine compound of the general formula (1), which is useful as a synthesis intermediate of a vasopressin antagonist. SOLUTION: General formula (1) Embedded image [Wherein, X represents a halogen atom. ] The benzazepine compound represented by the general formula (2) Embedded image [Wherein, X is as defined above. R represents a lower alkyl group. ] From a 3,1-benzoxazine compound or a salt thereof represented by the general formula (3): Embedded image [Wherein, X and R are the same as above. ] It is manufactured via a benzazepine compound represented by or a salt thereof. [Selection diagram] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5968466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102093293-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014104209-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102093293-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586905-B2
priorityDate 2003-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451392314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453171762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467943933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450592886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450592887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226440049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449497277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466270119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451370025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23055312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415927182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24190657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13955575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15559658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411241816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410271420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID294788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410445711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22903483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21932759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18354516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57079521

Total number of triples: 48.